334
Views
0
CrossRef citations to date
0
Altmetric
Case Series

Primary Malignant Melanoma of the Genitourinary Tract: Case Series of a Rare Form of Primary Mucosal Melanoma

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon &
Article: MMT67 | Received 24 Oct 2023, Accepted 26 Feb 2024, Published online: 25 Mar 2024

References

  • Hussein MR . Extracutaneous malignant melanomas. Cancer Invest. 26(5), 516–534 (2008).
  • Patrick R , Fenske NA , Messina JL . Primary mucosal melanoma. J. Am. Acad. Dermatol. 56(5), 828–834 (2007).
  • American Cancer Society . Cancer Facts & Figures 2022. American Cancer Society, Atlanta, GA, USA (2022).
  • Ainsworth AM , Clark WH , Mastrangelo M , Conger KB . Primary malignant melanoma of the urinary bladder. Cancer 37, 1928–1936 (1976).
  • Bhutani N , Kajal P , Pawar D . Primary malignant melanoma of the female urethra: report of a rare neoplasm of the urinary tract. Inter. J. Surg. Case Reports 41, 319–322 (2017).
  • Mahoney KM , Freeman GJ , McDermott DF . The next immune checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma. Clin. Ther. 37(4), 764–782 (2015).
  • Robert C , Long GV , Brady B et al. Nivolumab in previously untreated melanoma without BRAF mutation. N. Engl. J. Med. 372(4), 320–330 (2015).
  • Stein BS , Kendall R . Malignant melanoma of the genitourinary tract. J. Urol. 132(5), 859–868 (1984).
  • Filipkowski LA , Barker MA , Karram MM . Primary genitourinary melanoma presenting as voiding dysfunction. Int. Urogynecol. J. 20, 1141–1143 (2009).
  • Sergi MC , Filoni E , Triggiano G et al. Mucosal melanoma: epidemiology, clinical features, and treatment. Curr. Oncol. Rep. 25(11), 1247–1258 (2023).
  • Venyo AK . Melanoma of the urinary bladder: a review of the literature. Surg. Res. Pract. 2014, 605802 (2014).
  • Snajdar E , Ajo AR , Rosen K et al. Primary malignant melanoma of the urinary bladder. Cureus 13(3), e14067 (2021).
  • Nakamoto T , Inoue Y , Ueki T et al. Primary amelanotic malignant melanoma of the female urethra. Int. J. Urol. 14(2), 153–155 (2007).
  • Khayyat A , Esmaeil Pour M , Mousavi S et al. Primary malignant melanoma of the genitourinary system: a systemic review and report of eight cases. Cureus 14(10), e30444 (2022).
  • Zarei S , Voss JS , Jin L et al. Mutational profile in vulvar, vaginal, and urethral melanomas: review of 37 cases with focus on primary tumor site. Int. J. Gynecol. Pathol. 39, 587–594 (2020).
  • Piura B . Management of primary melanoma of the female urogenital tract. Lancet Oncol. 9(10), 973–981 (2008).
  • Si L , Zhang X , Shu Y et al. Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study. Front. Immunol. 13, 882471 (2022).
  • Hamid O , Robert C , Ribas A et al. Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. Br. J. Cancer 119(6), 670–674 (2018).
  • Patel SP , Othus M , Chen Y et al. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N. Engl. J. Med. 388(9), 813–823 (2023).
  • D’Angelo SP , Larkin J , Sosman JA et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J. Clin. Oncol. 35, 226–235 (2017).